MALORNI, LUCA
MALORNI, LUCA
Blockade of AP-1 potentiates endocrine therapy and overcomes resistance
2016 Malorni, Luca; Giuliano, Mario; Migliaccio, Ilenia; Wang, Tao; Creighton, Chad J.; Lupien, Mathieu; Fu, Xiaoyong; Hilsenbeck, Susan G.; Healy, Nuala; DE ANGELIS, Carmine; Mazumdar, Abhijit; Trivedi, Meghana V.; Massarweh, Suleiman; Gutierrez, Carolina; DE PLACIDO, Sabino; Jeselsohn, Rinath; Brown, Myles; Brown, Powel H.; Kent Osborne, C.; Schiff, Rachel
Ion trap mass spectrometry in the structural analysis of haemoglobin peptides modified by epichlorohydrin and diepoxybutane
2002 Miraglia, N.; Basile, A.; Pieri, M.; Acampora, A.; Malorni, L.; De Giulio, B.; Sannolo, N.
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series
2020 Schettini, F.; de Santo, I.; Rea, C. G.; Viggiani, M.; Buono, G.; de Angelis, C.; Cardalesi, C.; Lauria, R.; Giuliano, M.; Forestieri, V.; Thomas, G.; Maione, P.; Limite, G.; Accurso, A.; Malorni, L.; de Placido, S.; Arpino, G.
Activation of the IFN signaling pathway is associated with resistance to CDK4/6 inhibitors and immune checkpoint activation in ER-positive breast cancer
2021 De Angelis, C.; Fu, X.; Cataldo, M. L.; Nardone, A.; Pereira, R.; Veeraraghavan, J.; Nanda, S.; Qin, L.; Sethunath, V.; Wang, T.; Hilsenbeck, S. G.; Benelli, M.; Migliaccio, I.; Guarducci, C.; Malorni, L.; Litchfield, L. M.; Liu, J.; Donaldson, J.; Selenica, P.; Brown, D. N.; Weigelt, B.; Reis-Filho, J. S.; Park, B. H.; Hurvitz, S. A.; Slamon, D. J.; Rimawi, M. F.; Jansen, V. M.; Jeselsohn, R.; Osborne, C. K.; Schiff, R.
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial
2023 Malorni, L.; Bianchini, G.; Caputo, R.; Zambelli, A.; Puglisi, F.; Bianchi, G. V.; Del Mastro, L.; Paris, I.; Montemurro, F.; Allegrini, G.; Colleoni, M.; Tamberi, S.; Zamagni, C.; Cazzaniga, M. E.; Orditura, M.; Guarneri, V.; Castelletti, D.; Benelli, M.; Di Marino, M.; Arpino, G.; De Laurentiis, M.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Blockade of AP-1 potentiates endocrine therapy and overcomes resistance | 1.1 Articolo in rivista | 2016 | Malorni, Luca; Giuliano, Mario; Migliaccio, Ilenia; Wang, Tao; Creighton, Chad J.; Lupien, Mathieu; Fu, Xiaoyong; Hilsenbeck, Susan G.; Healy, Nuala; DE ANGELIS, Carmine; Mazumdar, Abhijit; Trivedi, Meghana V.; Massarweh, Suleiman; Gutierrez, Carolina; DE PLACIDO, Sabino; Jeselsohn, Rinath; Brown, Myles; Brown, Powel H.; Kent Osborne, C.; Schiff, Rachel | |
| Ion trap mass spectrometry in the structural analysis of haemoglobin peptides modified by epichlorohydrin and diepoxybutane | 1.1 Articolo in rivista | 2002 | Miraglia, N.; Basile, A.; Pieri, M.; Acampora, A.; Malorni, L.; De Giulio, B.; Sannolo, N. | |
| Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series | 1.1 Articolo in rivista | 2020 | Schettini, F.; de Santo, I.; Rea, C. G.; Viggiani, M.; Buono, G.; de Angelis, C.; Cardalesi, C.; Lauria, R.; Giuliano, M.; Forestieri, V.; Thomas, G.; Maione, P.; Limite, G.; Accurso, A.; Malorni, L.; de Placido, S.; Arpino, G. | |
| Activation of the IFN signaling pathway is associated with resistance to CDK4/6 inhibitors and immune checkpoint activation in ER-positive breast cancer | 1.1 Articolo in rivista | 2021 | De Angelis, C.; Fu, X.; Cataldo, M. L.; Nardone, A.; Pereira, R.; Veeraraghavan, J.; Nanda, S.; Qin, L.; Sethunath, V.; Wang, T.; Hilsenbeck, S. G.; Benelli, M.; Migliaccio, I.; Guarducci, C.; Malorni, L.; Litchfield, L. M.; Liu, J.; Donaldson, J.; Selenica, P.; Brown, D. N.; Weigelt, B.; Reis-Filho, J. S.; Park, B. H.; Hurvitz, S. A.; Slamon, D. J.; Rimawi, M. F.; Jansen, V. M.; Jeselsohn, R.; Osborne, C. K.; Schiff, R. | |
| Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trial | 1.1 Articolo in rivista | 2023 | Malorni, L.; Bianchini, G.; Caputo, R.; Zambelli, A.; Puglisi, F.; Bianchi, G. V.; Del Mastro, L.; Paris, I.; Montemurro, F.; Allegrini, G.; Colleoni, M.; Tamberi, S.; Zamagni, C.; Cazzaniga, M. E.; Orditura, M.; Guarneri, V.; Castelletti, D.; Benelli, M.; Di Marino, M.; Arpino, G.; De Laurentiis, M. |